Trial intelligence / Profile preview

Pilot study of GnRHa vs hCG for final oocyte maturation and endometrial receptivity in oocyte donors

2009-009429-26Phase 4Completed

Sponsor
Vrije Universiteit Brussel
Start
Mar 2009
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, randomised, open-label trial of human chorionic gonadotropin and buserelin in endometrial receptivity disorder and luteal insufficiency (4 arms), sponsored by Vrije Universiteit Brussel. Primary endpoints: Endometrial receptivity parameters and Luteal phase characteristics. Started Mar 2009; status: completed.

02

Drugs

human chorionic gonadotropinbuserelin
03

Conditions

endometrial receptivity disorderluteal insufficiency

Beyond the preview

Go deeper on 2009-009429-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-009429-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call